Peter DeMuth
Chief Tech/Sci/R&D Officer at ELICIO THERAPEUTICS, INC.
Net worth: - $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Connelly | M | 63 |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 6 years |
| Robert Ruffolo | M | 74 |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 6 years |
| Carol Ashe | F | 66 |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 4 years |
| Julian Adams | M | 69 |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 7 years |
| Megan Filoon | F | - | 1 years | |
| Karen Wilson | F | 61 | 1 years | |
| Allen Nissenson | M | 77 | 4 years | |
| Yekaterina Chudnovsky | F | 39 | 2 years | |
| Esther Welkowsky | F | - |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 4 years |
| Annette Matthies | M | 47 |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 3 years |
| Christopher Haqq | M | 58 |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 5 years |
| Christopher Monroe | M | 58 |
University of Maryland
| 17 years |
| Asher Epstein | M | - |
University of Maryland
| 20 years |
| A. Hart | M | 45 |
Massachusetts Institute of Technology
| 11 years |
| Brian Piekos | M | 49 | 1 years | |
| Millard S. Firebaugh | M | - |
University of Maryland
| 17 years |
| Linda Otis | M | 69 |
University of Maryland
| 19 years |
| Steven Hyman | M | 71 |
Massachusetts Institute of Technology
| 12 years |
| Jay Venkatesan | M | 52 | - | |
| Joy Seymour | F | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Timothy Heidel | M | - |
Massachusetts Institute of Technology
| 9 years |
| Assaf Segal | M | 51 |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 1 years |
| Avisha NessAiver | M | - |
University of Maryland
| 4 years |
| Sean Hunt | M | - |
Massachusetts Institute of Technology
| 5 years |
| Levent Demirekler | M | - |
University of Maryland
| 3 years |
| Huan Liu | M | - |
Massachusetts Institute of Technology
| 5 years |
| Denny Chu | M | - |
University of Maryland
| 2 years |
| Luke Chellis | M | - |
Massachusetts Institute of Technology
| 5 years |
| Megan Sparks | F | - |
University of Maryland
| 3 years |
| Jordan Steffy | M | - |
University of Maryland
| 6 years |
| Berk Ustun | M | - |
Massachusetts Institute of Technology
| 7 years |
| Devin Quinlan | M | - |
Massachusetts Institute of Technology
| 6 years |
| Troy Langford | M | - |
Massachusetts Institute of Technology
| 4 years |
| Ted Tomlinson | M | - |
Massachusetts Institute of Technology
| 5 years |
| Feyza Haskaraman | F | - |
Massachusetts Institute of Technology
| 4 years |
| Carlo Tursi | M | 41 |
Massachusetts Institute of Technology
| 9 years |
| Michael DiVecchia | M | - | 2 years | |
| Paul Witinski | M | - |
Massachusetts Institute of Technology
| 2 years |
| Eric Smith | M | - |
University of Maryland
| 7 years |
| Leonardo Banchik | M | - |
Massachusetts Institute of Technology
| 5 years |
| Zhen Li | M | 38 |
Massachusetts Institute of Technology
| 5 years |
| Mia Y. Qian | M | - |
Massachusetts Institute of Technology
| 5 years |
| Daphne Karydas | F | 49 |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | - |
| Ofer Gonen | M | 50 |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | 1 years |
| Eric Assaraf | M | - |
University of Maryland
| 9 years |
| Jia-Yi Har | F | - |
Massachusetts Institute of Technology
| 4 years |
| Samuel R. Moore | M | - |
Massachusetts Institute of Technology
University of Maryland
| 6 years |
| Fernando Mier-Hicks | M | - |
Massachusetts Institute of Technology
| 4 years |
| Jethro R. Solomon | M | - |
University of Maryland
| 5 years |
| Lachlan Ian Gowrie-Smith | M | 37 |
Massachusetts Institute of Technology
| 1 years |
| Mindaugas Leika | M | - |
Massachusetts Institute of Technology
| 1 years |
| David William Schultz | M | - |
Massachusetts Institute of Technology
| 1 years |
| BESTY MULE | F | - |
Massachusetts Institute of Technology
| 4 years |
| Mariapaola Testa | F | - |
Massachusetts Institute of Technology
| 2 years |
| Abdulaziz Alfalih | M | - |
Massachusetts Institute of Technology
| 4 years |
| Jesse Jenkins | M | - |
Massachusetts Institute of Technology
| 2 years |
| Samantha Bilow | F | - |
Massachusetts Institute of Technology
| 4 years |
| Mehul Chavada | M | - |
Massachusetts Institute of Technology
| 2 years |
| Jaideep Dudani | M | - |
Massachusetts Institute of Technology
| 5 years |
| Jonathan Coravos | M | - |
Massachusetts Institute of Technology
| 6 years |
| Ortez Peter | M | - |
Massachusetts Institute of Technology
| 4 years |
| Joan Smith | M | - |
Massachusetts Institute of Technology
| 5 years |
| Tal Levy | M | - |
Massachusetts Institute of Technology
| 2 years |
| Wei Feng Li | M | 45 |
Massachusetts Institute of Technology
| 3 years |
| Tsendai Chagwedera | M | - |
Massachusetts Institute of Technology
| 4 years |
| Brian Doyle | M | - |
Massachusetts Institute of Technology
| 4 years |
| Lauren Cipicchio | F | - |
Massachusetts Institute of Technology
| 4 years |
| Nam Pyo Suh | M | 88 |
Massachusetts Institute of Technology
| 42 years |
| Benjamin Mensah | M | - |
Massachusetts Institute of Technology
| 4 years |
| Anat Binur | M | - |
Massachusetts Institute of Technology
| 4 years |
| Kush Parmar | M | 42 |
Massachusetts Institute of Technology
| 8 years |
| Adam Kocoloski | M | - |
Massachusetts Institute of Technology
| 3 years |
| Mahesh Konduru | M | - |
Massachusetts Institute of Technology
| 2 years |
| Jacob Dweck | M | - |
Massachusetts Institute of Technology
| 4 years |
| Molly Bonakdarpour | F | - |
Massachusetts Institute of Technology
| 4 years |
| Gerardo Jose Balzaretti | M | - |
Massachusetts Institute of Technology
| 2 years |
| Allen H. Breed | M | - |
Massachusetts Institute of Technology
| 2 years |
| John David Cranor | M | - |
Massachusetts Institute of Technology
| 2 years |
| Armando Marchesan Neto | M | 48 |
Massachusetts Institute of Technology
| 1 years |
| Pat M. Sissman | M | - |
Massachusetts Institute of Technology
| 4 years |
| Kyle Adkins | M | - |
Massachusetts Institute of Technology
| 4 years |
| Armand Mignot | M | - |
Massachusetts Institute of Technology
| 4 years |
| Jeff Zhifan Chen | M | - |
Massachusetts Institute of Technology
| 4 years |
| Laura Stoppel | M | 38 |
Massachusetts Institute of Technology
| 5 years |
| Justin Butler | M | - |
Massachusetts Institute of Technology
| 2 years |
| Ilya Volodarsky | M | - |
Massachusetts Institute of Technology
| 4 years |
| Natalya Bailey | M | - |
Massachusetts Institute of Technology
| 3 years |
| Delian Asparouhov | M | - |
Massachusetts Institute of Technology
| 2 years |
| Haipeng Li | M | - |
University of Maryland
| 2 years |
| Jose Maria Fernandez | M | - |
Massachusetts Institute of Technology
| 1 years |
| Laura Deming | F | - |
Massachusetts Institute of Technology
| 2 years |
| Michael Gualtieri | M | - |
University of Maryland
| 4 years |
| Jai Kapadia | M | - |
Massachusetts Institute of Technology
| 2 years |
| Jacob Becraft | M | - |
Massachusetts Institute of Technology
| 6 years |
| Connor Popik | M | - |
Massachusetts Institute of Technology
| 4 years |
| Ani Sailesh | M | - |
Massachusetts Institute of Technology
| 4 years |
| Alex Fuiks | F | - |
Massachusetts Institute of Technology
| 4 years |
| Mona Vernon | F | - |
Massachusetts Institute of Technology
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 98 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Peter DeMuth
- Personal Network
